Budesonide Inhalation Suspension
NDC 76282-642, Budesonide, inhalant, from Exelan Pharmaceuticals, Inc..
- Product NDC
- 76282-642
- Status
- Listed
- Labeler
- Exelan Pharmaceuticals, Inc.
- Dosage form
- INHALANT
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205710
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76282-642 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE1 mg/2mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76282-642-38 | 76282064238 | 6 POUCH in 1 CARTON (76282-642-38) / 5 AMPULE in 1 POUCH (76282-642-37) / 2 mL in 1 AMPULE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d9656442-4587-4867-9a8c-5f5b0402936e
Use it
Look up 76282-642 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76282-642 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76282-642. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.